SAM
IRWD icon

Simplify Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Simplify Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,447
Closed -$40.2K – 151
2026
Q1 		$40.2K Buy
11,447
+501
+5% +$2.05K ﹤0.01% 141
2025
Q4 		$36.9K Buy
+10,946
New +$28.4K ﹤0.01% 141

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Simplify Asset Management's IRWD Position: Q2 2026 in Review

Simplify Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 11,447 shares — an estimated $40.2K sold.

Simplify Asset Management first reported a position in IRWD in Q4 2025 and held it in 2 quarters. The position peaked at $40.2K in Q1 2026. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Simplify Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Simplify Asset Management sold 11,447 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $40.2K.
  • Simplify Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Simplify Asset Management's Ironwood Pharmaceuticals position peaked at $40.2K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.